Answers are grounded in this paper and cite their sources.
Demonstrates that forskolin inhibits norepinephrine-induced contractions in rabbit aorta, indicating selective blockade of receptor-linked calcium pathways.
Effects of forskolin on the contractions in rabbit aorta were examined. The sustained contraction induced by 10(-6) M norepinephrine was inhibited by 10(-8)-10(-5) M forskolin in a concentration-dependent manner. In the high K+-depolarized and verapamil-treated aorta, the norepinephrine-induced sustained contraction was similarly inhibited by forskolin. However, forskolin showed only a slight inhibitory effect on the sustained contraction induced by 65.4 mM KCl. Forskolin inhibited the increase in Ca2+ influx due to norepinephrine, but not that due to high K+. In a Ca2+-free solution, 10(-6) M norepinephrine induced a transient contraction which is due to Ca2+ release from the store site. This contraction was inhibited by 3 X 10(-7)-10(-5) M forskolin. However, caffeine-induced transient contraction was not inhibited by 10(-5) M forskolin. 45Ca2+ in a cellular site was released by 10(-6) M norepinephrine or 10 mM caffeine. Forskolin inhibited the Ca2+ release induced by norepinephrine, but not that by caffeine. Forskolin increased the tissue cAMP content in resting, 10(-6) M norepinephrine-treated or 65.4 mM K+-treated aorta. It is concluded that forskolin inhibits the norepinephrine-induced sustained contraction by relatively selectively inhibiting the receptor-linked Ca2+ channel, and it inhibits the norepinephrine-induced transient contraction by inhibiting Ca2+ release from the cellular store.
No takes yet. Share an insight, caveat, or question.
ABE et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: